Encompass Health Corporation announced robust financial results for the fourth quarter ended December 31, 2025, demonstrating strong growth across key metrics. Net operating revenue increased by 9.9% to $1,544.6 million, while adjusted EBITDA grew by 15.9% to $335.6 million. Diluted earnings per share from continuing operations rose by 20.3% to $1.42, and adjusted earnings per share saw a 24.8% increase to $1.46. The company also reported a substantial increase in cash flows provided by operating activities, up 24.1% to $346.0 million, and adjusted free cash flow, up 23.6% to $235.4 million. Discharges increased by 5.3%, with same-store discharge growth at 3.2%, and net patient revenue per discharge grew by 4.1%.